Orthocell Submits Canada Regulatory Application to Commence Sales of Remplir™ into US$75million Canadian market

Orthocell has announced it has submitted an application to Health Canada for a Medical Device Licence (MDL) to sell its leading nerve repair product Remplir™ into the US$75 million Canadian nerve repair market.

Health Canada is the regulatory authority responsible for regulating the importation, manufacture, export, and supply of medical devices.

Evaluation of Orthocell’s application is now in progress with clearance expected in the second half of 2025.

Click to read the ASX Release.